PETALING JAYA: South Korean medical-device company AdipoLABs Co Ltd has selected Malaysia as its Asia-Pacific central hub, operating through Malaysian subsidiary AdipoLABs Healthcare (M) Sdn Bhd alongside Red & Blue Co Ltd.
The new office – the company’s first and only hub in Asia-Pacific – marks a key step in expanding its medtech footprint across the region.
AdipoLABs CEO Han Sung-ho said the expansion aims to strengthen the company’s leadership in noninvasive healthcare and support the development of a robust MedTech ecosystem in Malaysia and Asean.
“As a research- and development-driven medical company, our presence here will help drive knowledge transfer, foster R&D collaboration, provide industry-standard training and enhance the country’s preventive healthcare capabilities,” he said at the official launch of the regional office today.
To commemorate the milestone, AdipoLABs signed two memoranda of understanding (MoUs) with the University of Cyberjaya (UoC) to advance healthcare innovation, clinical research and talent development.
Han said combining the company’s hyperthermia technology with local expertise and academic rigour will accelerate the adoption of advanced solutions and improve patient outcomes globally. “We envision this collaboration as a blueprint for international healthcare partnerships.”
The first MoU establishes an internship programme with UoC’s physiotherapy programmes under the Faculty of Health, offering six-month placements and potential employment opportunities.
Students will gain hands-on experience with AdipoLABs’ Pain Bot device, enhancing their skills in pain detection and treatment, while Biomedical Engineering students will support the company’s technical operations.
As part of the initiative, interns may be placed at client facilities to demonstrate the device’s effectiveness and provide on-site support – an approach that strengthens client engagement and highlights potential pathways to permanent employment.
The collaboration extends to clinical research, with UoC academics and students conducting studies on AdipoLABs’ medical devices.
Findings will be published in reputable journals, providing scientific validation and strengthening evidence-based adoption of the company’s technologies.
AdipoLABs Healthcare director Dr Isaac R Joseph said the partnership gives UoC students valuable real-world exposure to technologies such as Pain Bot while expanding clinical research efforts. “It enhances pain management solutions for patients across Malaysia and Asean. We are committed to empowering future healthcare leaders.”
The second MoU – signed by AdipoLABs Malaysia, Red & Blue Co and UoC – focuses on knowledge transfer and medical device donation.
Under this agreement, AdipoLABs Malaysia will donate a Pain Bot unit to UoC, providing students access to cutting-edge pain detection and treatment technology and strengthening their competencies in advanced musculoskeletal care.
AdipoLABs, a Ministry of Health–registered medical-device establishment under the Medical Device Authority, brings strong regulatory credibility and a firm commitment to quality and innovation to the partnership.
University of Cyberjaya vice-chancellor Dr David Whitford said the collaboration represents a direct investment in the next generation of healthcare professionals.
“With the introduction of advanced rehabilitative technologies, our students gain access to international-standard tools and real-world innovation that will strengthen their confidence, competence and future careers.”
Professor Dr Yoo Seung-mo of South Korea, inventor of the Pain Bot, will serve as an adjunct professor at UoC. He will conduct on-site training and provide ongoing remote mentorship, ensuring students gain the highest level of expertise in utilising the Pain Bot and applying advanced pain management techniques.
Red & Blue Co is a South Korean company specialising in the development and distribution of advanced medical devices and healthcare solutions. As a key partner of AdipoLABs, Red & Blue Co is committed to supporting education
and training initiatives that promote the effective use of innovative pain detection and pain treatment techniques.
